Pharmacists in Marshfield, MO Accepting Medicare

11 Pharmacists found. Showing 1 - 11

Mr. Michael Anthony Vinehout, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 483 Pomme De Terre, Marshfield, MO 65706 Phone: 417-468-4442    Fax: 417-468-4462

Jonathan Jay Baughman, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14740 State Highway 38, Marshfield, MO 65706 Phone: 417-468-6151    Fax: 417-859-2260

Mr. Joseph Thomas Daugherty, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1365 Spur Dr, Marshfield, MO 65706 Phone: 417-468-2530    Fax: 417-859-7116

Patrick John Blinzler, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 483 Pomme De Terre, Marshfield, MO 65706 Phone: 417-859-5055

Dr. Rebecca Marie Grable, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1260 Spur Dr, Marshfield, MO 65706 Phone: 417-859-5394    Fax: 417-859-5401

Monna Vay Devoto, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14740 State Highway 38, Marshfield, MO 65706 Phone: 417-859-2260    Fax: 417-859-2260

Ira Mccracken, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 452 Forest Dr, Marshfield, MO 65706 Phone: 417-872-8836

Mr. Lonnie D Hawkins, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1260 Spur Dr, Marshfield, MO 65706 Phone: 417-859-5394

Cynthia Jane Olson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1260 Spur Dr, Marshfield, MO 65706 Phone: 417-859-5394

Dr. Tara Kay Isringhausen-thomas, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14740 State Highway 38, Marshfield, MO 65706 Phone: 417-468-6151    Fax: 417-859-2260

Laura Poppe, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1260 Spur Dr, Marshfield, MO 65706 Phone: 417-859-5394

News Archive

Highland Therapeutics subsidiary reports positive HLD-200 Phase-1 results in ADHD patients

Highland Therapeutics, Inc., a specialty pharmaceutical company based in the MaRS Discovery District in Toronto, today announced that its wholly owned subsidiary has generated positive Phase-1 results for HLD-200 - a novel formulation of methylphenidate being developed to treat the symptoms associated with Attention-Deficit/Hyperactivity Disorder.

Australian Government has provided $200 million over seven years to independent medical research

The Australian Government has provided an extra $200 million over seven years to independent medical research institutes to help fund overhead costs to ensure they are well equipped to focus on their vital work.

UC Davis develops new sensor for use in medical applications

A new kind of flexible, transparent pressure sensor, developed at the University of California, Davis, for use in medical applications, relies on a drop of liquid.

A child's risk of becoming obese may begin before birth and continue throughout infancy

A child's risk of becoming obese may begin before birth and continue throughout infancy and early childhood - critical periods for cellular growth and development, according to research results discussed during a national conference and outlined in the October supplement to Pediatrics.

FDA approves Onsolis pain reliever for cancer patients

The U.S. Food and Drug Administration today approved Onsolis, medication intended for certain patients with cancer to help manage breakthrough pain – severe flares of pain that break through regular pain medication.

Read more Medical News

› Verified 5 days ago